TY  - JOUR
AU  - Jiménez-Jáimez, Juan
AU  - Macías-Ruiz, Rosa
AU  - Bermúdez-Jiménez, Francisco
AU  - Rubini-Costa, Ricardo
AU  - Ramírez-Taboada, Jessica
AU  - Flores, Paula Isabel García
AU  - Gallo-Padilla, Laura
AU  - García, Juan Diego Mediavilla
AU  - García, Concepción Morales
AU  - Suárez, Sara Moreno
AU  - Molina, Celia Fignani
AU  - López, Miguel Álvarez
AU  - Tercedor, Luis
PY  - 2020
DO  - 10.1038/s41598-020-78360-9
UR  - http://hdl.handle.net/10668/16760
T2  - Scientific reports
AB  - SARS-CoV-2 is a rapidly evolving pandemic causing great morbimortality. Medical therapy with hydroxicloroquine, azitromycin and protease inhibitors is being empirically used, with reported data of QTc interval prolongation. Our aim is to assess QT...
LA  - en
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Anti-Bacterial Agents
KW  - Antimalarials
KW  - Antiviral Agents
KW  - Azithromycin
KW  - Critical Illness
KW  - Drug Therapy, Combination
KW  - Electrocardiography
KW  - Female
KW  - Humans
KW  - Hydroxychloroquine
KW  - Long QT Syndrome
KW  - Male
KW  - Middle Aged
KW  - Potassium
KW  - Protease Inhibitors
KW  - Risk Factors
KW  - SARS-CoV-2
KW  - Ventricular Fibrillation
KW  - Young Adult
KW  - COVID-19 Drug Treatment
TI  - Absence of relevant QT interval prolongation in not critically ill COVID-19 patients.
TY  - research article
VL  - 10
ER  -